PSI Opens Office in Taiwan

20-Sep-2017 Intellasia | BusinessWire | 10:00 PM Print This Post

ZUG, Switzerland–(BUSINESS WIRE)–PSI CRO has announced opening offices in Taiwan, listed as Taiwan PSI
Health Development Co. Ltd. at Level 37, TAIPEI 101 TOWER, No. 7, Sec.5,
Xinyi Road, Taipei 110, Taiwan.


“We are excited about the PSI office opening,” says Ava Lu, PSI’s
Clinical Operations Manager in Taipei. “We can now bring our staff under
the same roof and build a proper PSI home in Taiwan. Our expansion is
driven by many clinical trial requests from global sponsors in oncology,
infections, IBD (ulcerative colitis, Crohn’s Disease), and other
therapeutic areas. We aim to make Taiwan a reliable and consistent
contributor to the global clinical trials that PSI manages worldwide. We
are keen to keep up with PSI’s unchanging promise of on-time delivery.”

PSI’s expansion into Asia Pacific started in 2017, when PSI opened
offices in Sydney, Australia and Seoul, South Korea. PSI is focused on
strengthening its global capabilities of delivering clinical trial
programs in a variety of therapeutic areas on time and on budget.

“PSI’s global reach in an important differentiator of an agile mid-sized
CRO in today’s clinical trial market,” says Katarzyna Skalowska, Global
Head of Clinical Operations. “Clinical trials are becoming more complex,
while targeting smaller patient populations and requiring a wider
geographic spread. PSI is now fully operational on five continents
offering robust site relationships with investigators across North
America, South America, Africa, Europe, Asia and Australia.”

About PSI CRO:

PSI is a privately-owned, full-service contract
research organization (CRO) operating globally. PSI’s reputation in the
market place is that of a no-nonsense CRO, capable of saving
pharmaceutical sponsors millions of development dollars by consistently
meeting clinical trial timelines. PSI’s global
reach
 supports clinical trials across multiple countries and
continents. PSI is known to be highly selective about the work that they
pursue. PSI has exceptionally high repeat and referral business rates,
while maintaining minimal staff turnover. PSI is committed to being the
best CRO in the world as measured by its customers and its employees. In
the bi-annual CenterWatch Investigator Surveys of 2015 and 2017, PSI was
repeatedly voted Number One Global CRO.

Global headquarters are located in Switzerland at 113a Baarerstrasse,
6300 Zug.

www.psi-cro.com

Contacts

PSI CRO
Natania Barron
Marketing@psi-cro.com

 


Category: BusinessWire, PRAsia

Print This Post